Market Overview:
The global cancer diagnostics device market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of cancer, technological advancements in cancer diagnostics devices, and rising demand for personalized medicine. The global cancer diagnostics device market is segmented by type into companion diagnostics and molecular diagnostics. Companion diagnostics are used along with targeted therapies to identify patients who are likely to respond to the therapy. Molecular diagnostic tests detect changes in the DNA or RNA of cells, which can indicate the presence of cancer or help determine its subtype. The global cancer diagnostics device market is segmented by application into lung, breast, colorectal, prostate, cervical and others (including head and neck cancers). Lung Cancer accounted for the largest share of the global oncology diagnostic devices market in 2017 owing to high incidence rates globally coupled with increasing adoption of advanced technologies such as liquid biopsy for early diagnosis. Breast Cancer was second largest application area in 2017 due high prevalence rates among women across different geographies coupled with growing awareness about breast health screening programs worldwide . Colorectal Cancer was third largest application area due high incidence rates globally coupled with growing preference for minimally invasive procedures over traditional surgery procedures . Prostate Cancer was fourth largest application area due rising prevalence rates among men across different geographies .
Product Definition:
A cancer diagnostics device is a piece of equipment used to detect the presence of cancer in a patient. This type of device can be used to diagnose any type of cancer, but is most commonly used to identify breast, ovarian, and prostate cancers. The importance of these devices cannot be overstated; early diagnosis can often mean the difference between life and death for patients with certain types of cancer.
Companion Diagnostics:
The global companion diagnostics market is expected to witness significant growth over the forecast period. The major factor that propels the growth of this market includes increasing demand for early and accurate diagnosis, growing R&D initiatives by various key players in order to expand their product portfolio, rising prevalence of cancer and other chronic diseases coupled with high unmet medical needs in emerging economies.
Molecular Diagnostics:
Molecular diagnostics (MDx) is an analytical technology used for the detection, identification and characterization of genetic material (DNA & RNA) structure and its disease-causing mutations. MDx is majorly used in oncology to detect cancer-associated alterations in genes which are responsible for the development of tumors. The other applications of molecular diagnostic techniques include infectious diseases testing, gene mapping, drug discovery & development studies among others.
Global Molecular Diagnostics.
Application Insights:
The lung cancer segment dominated the market in 2017 owing to the rising prevalence of the disease. According to data published by NCBI, around 160,170 new cases of lung cancer were registered in 2016 globally. Increasing tobacco and alcohol consumption are among major factors contributing towards growth of this segment.
Cervical Cancer is expected to be one of the fastest-growing segments during forecast period due to increasing incidence rate and awareness about early detection methods such as PAP smears and HPV tests among women aged 25¢â‚¬â€œ44 years across various regions including North America, Europe and Asia Pacific. Moreover, introduction of advanced liquid biopsy technique for treatment planning which helps deliver precise doses at a faster pace is anticipated to increase adoption rate for these diagnostic devices over the forecast period.
Regional Analysis:
North America dominated the global cancer diagnostics device market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and availability of reimbursement facilities for patients. The U.S.-based companies are involved in research activities to develop new assays and improve existing ones that would help clinicians make better-informed decisions about treatment options for their patients faster than other countries do.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing cases of cancer among Asian population coupled with rising disposable income & healthcare expenditure per capita as compared to other regions. Moreover, governments are continuously investing in R&D activities relatedto early diagnosis which is further anticipated boost growth over the forecast period ‰â€°â€°â€°â€° “‰ ☘˜™”' '-' -.-.
Growth Factors:
- Increasing incidence of cancer: The global incidence of cancer is increasing at an alarming rate. This is primarily due to the aging population and the rising prevalence of lifestyle-related cancers. This is expected to drive the demand for cancer diagnostics devices in the coming years.
- Technological advancements: The development of novel technologies has led to the introduction of advanced and sophisticated cancer diagnostics devices in the market. This is likely to boost market growth in the coming years.
- Growing awareness about early detection: There is a growing awareness among people about the importance of early detection for various diseases, including cancer. This is likely to propel demand for cancer diagnostics devices in future years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Cancer Diagnostics Device Market Research Report
By Type
Companion Diagnostics, Molecular Diagnostics
By Application
Lung, Breast, Colorectal, Prostate, Cervical, Others
By Companies
Abbott Diagnostics, Agilent Technologies, BD, bioMérieux, Qiagen, Roche Diagnostics, Abbott Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
201
Number of Tables & Figures
141
Customization Available
Yes, the report can be customized as per your need.
Global Cancer Diagnostics Device Market Report Segments:
The global Cancer Diagnostics Device market is segmented on the basis of:
Types
Companion Diagnostics, Molecular Diagnostics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Lung, Breast, Colorectal, Prostate, Cervical, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Diagnostics
- Agilent Technologies
- BD
- bioMérieux
- Qiagen
- Roche Diagnostics
- Abbott Diagnostics
Highlights of The Cancer Diagnostics Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Companion Diagnostics
- Molecular Diagnostics
- By Application:
- Lung
- Breast
- Colorectal
- Prostate
- Cervical
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cancer Diagnostics Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A cancer diagnostics device is a medical device that is used to diagnose cancer.
Some of the major players in the cancer diagnostics device market are Abbott Diagnostics, Agilent Technologies, BD, bioMƒÂ©rieux, Qiagen, Roche Diagnostics, Abbott Diagnostics.
The cancer diagnostics device market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cancer Diagnostics Device Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Cancer Diagnostics Device Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Cancer Diagnostics Device Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Cancer Diagnostics Device Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Cancer Diagnostics Device Market Size & Forecast, 2018-2028 4.5.1 Cancer Diagnostics Device Market Size and Y-o-Y Growth 4.5.2 Cancer Diagnostics Device Market Absolute $ Opportunity
Chapter 5 Global Cancer Diagnostics Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cancer Diagnostics Device Market Size Forecast by Type
5.2.1 Companion Diagnostics
5.2.2 Molecular Diagnostics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cancer Diagnostics Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cancer Diagnostics Device Market Size Forecast by Applications
6.2.1 Lung
6.2.2 Breast
6.2.3 Colorectal
6.2.4 Prostate
6.2.5 Cervical
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cancer Diagnostics Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cancer Diagnostics Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cancer Diagnostics Device Analysis and Forecast
9.1 Introduction
9.2 North America Cancer Diagnostics Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cancer Diagnostics Device Market Size Forecast by Type
9.6.1 Companion Diagnostics
9.6.2 Molecular Diagnostics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cancer Diagnostics Device Market Size Forecast by Applications
9.10.1 Lung
9.10.2 Breast
9.10.3 Colorectal
9.10.4 Prostate
9.10.5 Cervical
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cancer Diagnostics Device Analysis and Forecast
10.1 Introduction
10.2 Europe Cancer Diagnostics Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cancer Diagnostics Device Market Size Forecast by Type
10.6.1 Companion Diagnostics
10.6.2 Molecular Diagnostics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cancer Diagnostics Device Market Size Forecast by Applications
10.10.1 Lung
10.10.2 Breast
10.10.3 Colorectal
10.10.4 Prostate
10.10.5 Cervical
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cancer Diagnostics Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cancer Diagnostics Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cancer Diagnostics Device Market Size Forecast by Type
11.6.1 Companion Diagnostics
11.6.2 Molecular Diagnostics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cancer Diagnostics Device Market Size Forecast by Applications
11.10.1 Lung
11.10.2 Breast
11.10.3 Colorectal
11.10.4 Prostate
11.10.5 Cervical
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cancer Diagnostics Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Cancer Diagnostics Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cancer Diagnostics Device Market Size Forecast by Type
12.6.1 Companion Diagnostics
12.6.2 Molecular Diagnostics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cancer Diagnostics Device Market Size Forecast by Applications
12.10.1 Lung
12.10.2 Breast
12.10.3 Colorectal
12.10.4 Prostate
12.10.5 Cervical
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cancer Diagnostics Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cancer Diagnostics Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cancer Diagnostics Device Market Size Forecast by Type
13.6.1 Companion Diagnostics
13.6.2 Molecular Diagnostics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cancer Diagnostics Device Market Size Forecast by Applications
13.10.1 Lung
13.10.2 Breast
13.10.3 Colorectal
13.10.4 Prostate
13.10.5 Cervical
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cancer Diagnostics Device Market: Competitive Dashboard
14.2 Global Cancer Diagnostics Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Diagnostics
14.3.2 Agilent Technologies
14.3.3 BD
14.3.4 bioMérieux
14.3.5 Qiagen
14.3.6 Roche Diagnostics
14.3.7 Abbott Diagnostics